An increase in public reporting of aortic valve surgery outcomes has been tied to a decrease in AVR access for patients with infective endocarditis—the unintended consequence of a push for greater transparency in healthcare.

Medtronic on Oct. 7 announced the launch of its EV ICD pivotal study—a prospective, pre-market trial designed to assess the efficacy of an extravascular system in treating dangerous arrhythmias.

Doctors at the University of New Mexico Hospital used an extracorporeal membrane oxygenation system to treat a cardiac arrest patient in the field for the first time last week, the Albuquerque Journal reports.

A study published just two months after the FDA issued a statement acknowledging a late mortality signal with paclitaxel-coated and -eluting stents and balloons suggests the devices are actually safe in patients with lower extremity artery disease.

Around one in five heart patients in cardiac rehabilitation are depressed, anxious or stressed, according to a new study published in the European Journal of Preventive Cardiology.

Results from the late-breaking TWILIGHT trial suggest that, among high-risk patients who have undergone PCI and completed three months of dual antiplatelet therapy, it’s safer to continue treatment with ticagrelor alone rather than add aspirin to that cocktail.

Teens who use or abuse cannabis could be at risk for a number of cardiac arrhythmias, according to research published in the American Journal of Cardiology, including atrial flutter or fibrillation, palpitations and long QT syndrome.

The New York City Department of Health and Mental Hygiene has expanded its Health Bucks program to allow pharmacists to “prescribe” produce to low-income residents with high blood pressure.